In a randomized controlled trial, patients treated with LINX experienced improved quality of life (GERD-HRQL scores) while patients treated with BID PPIs did not.1*
98%
of LINX patients were free from moderate to severe regurgitation 12 months post-op1†
91%
of patients treated with LINX had discontinued GERD medication at study completion1‡
70%
of patients treated with LINX had normalized DeMeester scores at 12-months1§
Features & Benefits

Simply designed to be simple
LINX is a flexible ring of small magnets placed around the LES during a minimally invasive procedure and requires no alteration to stomach anatomy.2,3 ¶ The magnetic strength of the beads is designed to help a weak LES close to prevent acid reflux.4 When patients swallow LINX opens temporarily to allow food and liquid to pass.4

Retained ability to belch and vomit.5,6β
LINX preserves physiological function to belch and vomit.5 The titanium beads open and close to let food down, and if it needs to come up, it can.

MRI conditional€
Patients with a LINX device can undergo a wide range of diagnostic imaging tests, including X-Ray, ultrasound, PET scan, CT scan and MRI (Up to 1.5 T).€

LINX Reflux Management System
Esophagus Sizing Tool
Designed for one-handed use and sizing confidence7\\
The shaft was designed to prevent bending of the device.8\\
The numerical indicator was designed to be highly legible from both sides of the device to support optimal sizing.9
In a long-term follow-up study, LINX patients reported sustained improvement in quality of life (GERD-HRQL score) up to 12 years after surgery.10¥
93.8%
overall patient satisfaction 10-12 years post-op10$
~91%
of patients 10-12 years post LINX implantation were free from daily PPI use.10Ω
0%
No device erosions or migrations seen in a 6-12 years post-op study10II
Resources
Resources
Outcomes obtained from multiple clinical studies

Low incidence of side effects6**
Generally, a short, minimally invasive procedure.11-13††
The device maintains normal gastroesophageal junction and gastric anatomy2,3 ¶ and preserves physiologic function (belch and vomit).5,6‡‡ LINX was associated with fewer side effects than Nissen fundoplication.6**

Consistent results in symptom improvement.5,6,14§§
88% of patients reported that bothersome heartburn had been eliminated 5 years after treatment with LINX.5¶¶ 85% of patients were free from dependence on daily reflux medication5ββ and 98% of patients eliminated moderate to severe regurgitation 5 years after treatment with LINX.5€€

Sustained improvement in HRQL at 5 years5¥¥
At 5 years after LINX implant :
- patients reported significant improvement in health-related quality of life and satisfaction5$$
- a target reduction in GERD-HRQL score in 83% of patients was achieved5ΩΩ
- a target reduction in PPI usage in 89% of patients was achieved5***

LINX was superior to PPI in reducing regurgitation1†
In a randomized controlled trial, patients treated with LINX experienced improved quality of life (GERD-HRQL scores) while patients treated with BID PPIs did not.1* Patients with regurgitation and associated heartburn symptoms responded to LINX even when non-responsive to PPI therapy.1†††
Supporting Documentation
Product Support
-
LINX Sizing Tool Product Information
View PDF
-
LINX Sizing Tool User Guide
View PDF
-
Select all documents (2)
© Johnson & Johnson Medical NV., 2023.
This site is published by Johnson & Johnson Medical N.V., which is solely responsible for its contents and is intended for EMEA audiences only. This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.
*As of March 2017, per internal research conducted by Ethicon.
Please refer always to the Instructions for Use / Package Insert that come with the device for the most current and complete instructions.